Salta alla navigazione principale Salta alla ricerca Salta al contenuto principale

Spatial transcriptomic validation of a biomimetic model of fibrosis enables re-evaluation of a therapeutic antibody targeting LOXL2

  • Joseph A. Bell
  • , Elizabeth R. Davies
  • , Christopher J. Brereton
  • , Milica Vukmirovic
  • , James J.W. Roberts
  • , Kerry Lunn
  • , Leanne Wickens
  • , Franco Conforti
  • , Robert A. Ridley
  • , Jessica Ceccato
  • , Lucy N. Sayer
  • , David A. Johnston
  • , Andres F. Vallejo
  • , Aiman Alzetani
  • , Sanjay Jogai
  • , Ben G. Marshall
  • , Aurelie Fabre
  • , Luca Richeldi
  • , Phillip D. Monk
  • , Paul Skipp
  • Naftali Kaminski, Emily Offer, Yihua Wang, Donna E. Davies, Mark G. Jones
  • University of Southampton
  • Yale University
  • Synairgen PLC
  • NIHR Southampton Biomedical Research Centre and Clinical and Experimental Sciences
  • University Hospital Southampton NHS Foundation Trust
  • University College Dublin
  • Medicines Discovery Catapult

Risultato della ricerca: Contributo in rivista › Articolo

Lingua originaleInglese
pagine (da-a)3-20
Numero di pagine18
RivistaCell Reports Medicine
DOI
Stato di pubblicazionePubblicato - 2024

Keywords

  • LOXL2
  • disease-relevant biomimetic models
  • fibrosis
  • spatial transcriptomics
  • target engagement

Cita questo